Showing 1051-1060 of 1372 results for "".
- BeautyHealth’s Hydrafacial Partners with Organicell for Exosome Boosterhttps://modernaesthetics.com/news/beautyhealths-hydrafacial-partners-with-organicell-for-exosome-booster/2473300/The Beauty Health Company is joining forces with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin for Hydrafacial. “We are excited to begin development with Organicell to co-create a potentially
- Allergan Aesthetics and BOTOX Cosmetic Reveal New 'See Yourself' Campaign Casthttps://modernaesthetics.com/news/allergan-aesthetics-and-botox-cosmetic-reveal-new-see-yourself-campaign-cast/2473299/Allergan Aesthetics is unveiling the 25 real patients – of all forms, genders, ethnicities and backgrounds – who were selected to participate in the latest iteration of the BOTOX Cosmetic 'See Yourself' campaign. After receiving nearly 20,000 submissions t
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERMhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-100-million-syringes-of-juvederm/2473294/Drumroll, please…Allergan Aesthetics, an AbbVie company, has produced and shipped 100 million syringes of JUVÉDERM products globally. Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in mo
- Allergan Aesthetics Announces Double Allē Points Promotion for Juvederm Usershttps://modernaesthetics.com/news/allergan-aesthetics-announces-double-alle-points-promotion-for-juvederm-users/2473281/Consumers can earn double points in Allē, Allergan Aesthetics' loyalty rewards program, when treated with two or three syringes from the JUVÉDERM Collection of Fillers during the same visit. Allē points can be redeemed for future Allē-eligible treatments or products.&nb
- The Newest Xeomin Brand Partner is Joe Jonashttps://modernaesthetics.com/news/the-newest-xeomin-brand-partner-is-joe-jonas/2473280/Joe Jonas is the latest Xeomin (incobotulinumtoxinA) brand partner, Merz Aesthetics announced. The U.S. partnership with Jonas kicks off a new ‘Beauty on Your Terms’ campaign for Xeomin and represents the first time the singer, songwriter and actor has pa
- New from Senté: Cysteamine HSA Pigment & Tone Correctorhttps://modernaesthetics.com/news/new-from-sente-cysteamine-hsa-pigment-tone-corrector/2473279/Cysteamine HSA Pigment & Tone Corrector from Senté has launched to safely and effectively target pigmentation in all skin tones. The hydroquinone-free formula is safe for long-term use and formulated for all skin types, including dry or sensitive skin. Cystea
- Alma Rolls Out Alma Hybrid and Alma TED Systems in Canadahttps://modernaesthetics.com/news/alma-rolls-out-alma-hybrid-and-alma-ted-systems-in-canada/2473278/Alma Hybrid and Alma TED systems are now commercially available in Canada, the company reports. Alma Hybrid, the first laser platform to include an ablative 10,600 nm (CO2) laser and a non-ablative 1570 nm laser for skin resurfacing that offers a comprehensive solution to utilize each b
- Aesthetics Biomedical Inc. Scores Third U.S. Patent for SoME Skincarehttps://modernaesthetics.com/news/aesthetics-biomedical-inc-scores-third-us-patent-for-some-skincare/2473277/Aesthetics Biomedical Inc. scored its third U.S. patent for “biological preserving composition and methods of use” for its SoME skincare product line. The patent covers topical compositions for combining biologics with skincare preserving the exclusivity of SoME Skincar
- JUVÉDERM VOLUX XC Scores FDA Nod for Jawline Definitionhttps://modernaesthetics.com/news/juvederm-volux-xc-scores-fda-nod-for-jawline-definition/2473275/The U.S. FDA has given its nod to JUVÉDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition. "The approval of JUVÉDERM VOLUX XC represents the largest leap in innova